Gene mutation may unlock L-Carnitine's power for sperm health
NCT ID NCT07402759
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether men with a specific gene mutation (TDRD9) get more benefit from L-carnitine, a common supplement, to improve sperm count and movement. About 50 men with low sperm count and motility will take L-carnitine for 3 months. Researchers will compare changes in sperm quality between those with and without the mutation to see if genetics can guide personalized infertility treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALE INFERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qena university hospital
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut protein zonulin: a hidden clue to male infertility?
- Could a simple supplement revive sperm health and testosterone?
- Sperm protein could be key to unlocking male infertility
- Surgery for enlarged scrotum veins may boost sperm health by reducing immature cells
- One cut instead of two: could a single incision improve varicocele surgery recovery?
- Can a common breast cancer drug and a supplement boost sperm quality?